Your session is about to expire
← Back to Search
SPIDER Approach for Overmedication in Elderly (SPIDER Trial)
N/A
Waitlist Available
Led By Michelle Greiver, MD
Research Sponsored by University of Toronto Practice Based Research Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
SPIDER Trial Summary
This trial is to study whether SPIDER, a Structured Process Informed by Data, Evidence and Research, can reduce Potentially Inappropriate Prescriptions (PIPs) for elderly patients who are on multiple medications.
Who is the study for?
The SPIDER trial is for elderly patients aged 65 or older who have visited their family doctor at least once in the past two years and are on ten or more medications. Family doctors, nurses, pharmacists, and staff from practices that use electronic health records and are part of a research network can join if they agree to participate.Check my eligibility
What is being tested?
SPIDER aims to reduce potentially inappropriate prescriptions among elderly patients through a quality improvement process supported by data from Electronic Medical Records. Practices will learn collaboratively to improve care strategies tailored to local needs versus usual care methods.See study design
What are the potential side effects?
Since SPIDER is not a drug but an intervention involving education and practice changes, there are no direct side effects like those seen with medication. However, changes in prescription practices may indirectly affect patient health.
SPIDER Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Potentially Inappropriate Prescriptions (PIPs).
Secondary outcome measures
Care provider perception of SPIDER
Cost-utility of SPIDER
Patient perception of SPIDER
SPIDER Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: SPIDERExperimental Treatment2 Interventions
QI Learning Collaboratives.
Group II: Usual CarePlacebo Group1 Intervention
Standard primary care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care
1990
Completed Phase 4
~7700
Find a Location
Who is running the clinical trial?
Fonds de la Recherche en Santé du QuébecOTHER_GOV
80 Previous Clinical Trials
46,444 Total Patients Enrolled
Université de MontréalOTHER
214 Previous Clinical Trials
102,667 Total Patients Enrolled
Dalhousie UniversityOTHER
167 Previous Clinical Trials
403,034 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 65 or older, visited a doctor in the last 2 years, and had 10+ different prescriptions last year.I am under 65, haven't seen a doctor in 2 years, or had less than 10 prescriptions last year.
Research Study Groups:
This trial has the following groups:- Group 1: SPIDER
- Group 2: Usual Care
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment still open for this research initiative?
"As indicated on clinicaltrials.gov, this trial posted in March 2018 is no longer recruiting patients; however, 54 other trials are currently welcoming volunteers."
Answered by AI
How many health care facilities are involved in conducting this experiment?
"Patients may be accepted into this trial at several medical sites, including Réseau de recherche en soins primaires de l'Université de Montréal (RRSPUM) in Laval, Quebec, Southern Alberta Primary Care Research Network (SAPCReN) in Calgary, Alberta, and Maritime Family Practice Research Network (MaRNet-FP) in Halifax. There are seven other locations available as well."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger